Profound Radiographic and Tumor-Lytic Response of Locally Advanced Pancreatic Adenocarcinoma to a Non-Systemic-Chemotherapy Multimodal Protocol—Fractionated Radiotherapy with Capecitabine Radiosensitization, Intratumoral EpCAM/CD3 Bispecific Antibody, Allogeneic NK and Autologous Lymphocyte Cellular Therapy, and Sequenced Pembrolizumab Following Failure of Conventional Gemcitabine-Based Therapy